Light grey background with rounded corners

Peptide Insights – Immunology & Virus Research with peptides&elephants

Discover how peptides illuminate pathogen and tumor biology – from EBV-driven lymphomas and TIL-based melanoma therapies to PRAME-targeted strategies and Influenza A Matrix Protein 1.

Schematic diagram of Epstein-Barr virus labeled with lipid bilayer, nucleocapsid, DNA genome, inner and outer tegument, and various surface proteins.

Decoding EBV: From Viral Biology to Therapeutic Target

The Epstein–Barr Virus (EBV) is one of the most common human viruses, but its ability to persist undetected poses severe health risks. Explore our latest research updates to see how we are uncovering the virus's mechanisms and turning its own biology against it:

Epstein–Barr Virus: Biology and Early Infection – Understand the fundamental mechanics of how EBV establishes its initial foothold in the human body.
How a Synthetic LMP-1 Peptide Revealed Mechanism of EBV-Associated Lymphomas – Discover how synthetic peptides are shedding light on the precise pathways EBV uses to drive lymphoma development.
Peptide Alarm Therapy: Viral Peptides Against Tumoral Immune Escape – Learn about an innovative therapeutic approach that leverages viral peptides to strip away the tumor's defense mechanisms and counter EBV-associated immune escape.

Decoding EBV: From Viral Biology to Therapeutic Target

The Epstein–Barr Virus (EBV) is one of the most common human viruses, but its ability to persist undetected poses severe health risks. Explore our latest research updates to see how we are uncovering the virus's mechanisms and turning its own biology against it:

Epstein–Barr Virus: Biology and Early Infection – Understand the fundamental mechanics of how EBV establishes its initial foothold in the human body.
How a Synthetic LMP-1 Peptide Revealed Mechanism of EBV-Associated Lymphomas – Discover how synthetic peptides are shedding light on the precise pathways EBV uses to drive lymphoma development.
Peptide Alarm Therapy: Viral Peptides Against Tumoral Immune Escape – Learn about an innovative therapeutic approach that leverages viral peptides to strip away the tumor's defense mechanisms and counter EBV-associated immune escape.

Cancer/Testis Antigens for Precision Immunotherapy

Cancer/Testis Antigens (CTAs) represent one of the most promising frontiers in oncology. Because their normal expression is restricted to immune-privileged germ cells, their aberrant re-activation in various tumors makes them exceptionally precise targets for cancer immunotherapy. Explore these unique proteins and how they are advancing tumor targeting and biomarker discovery:

NY-ESO-1: A Cancer/Testis Antigen with High Immunogenic Potential – Explore one of the most well-characterized CTAs in history, renowned for its ability to provoke robust, spontaneous immune responses and drive next-generation immunotherapeutic trials.
PRAME: Biomarker and Therapeutic Target in Multiple Malignancies – Examine the clinical significance of PRAME, a key CTA that acts as both a valuable diagnostic biomarker and an attractive target for T-cell receptor (TCR) therapies across diverse cancers.

Scientific illustration of Cancer-Testis Antigens (CTAs) expression on tumor cells for targeted immunotherapy.

Cancer/Testis Antigens for Precision Immunotherapy

Cancer/Testis Antigens (CTAs) represent one of the most promising frontiers in oncology. Because their normal expression is restricted to immune-privileged germ cells, their aberrant re-activation in various tumors makes them exceptionally precise targets for cancer immunotherapy. Explore these unique proteins and how they are advancing tumor targeting and biomarker discovery:

NY-ESO-1: A Cancer/Testis Antigen with High Immunogenic Potential – Explore one of the most well-characterized CTAs in history, renowned for its ability to provoke robust, spontaneous immune responses and drive next-generation immunotherapeutic trials.
PRAME: Biomarker and Therapeutic Target in Multiple Malignancies – Examine the clinical significance of PRAME, a key CTA that acts as both a valuable diagnostic biomarker and an attractive target for T-cell receptor (TCR) therapies across diverse cancers.

Two schematic diagrams of binding grooves labeled 'MHC class I binding groove' on top and 'MHC class II binding groove' below.

Peptide Binding to MHC Class I and II Molecules

Discover how the binding grooves differ between MHC Class I and II molecules and how this affects antigen presentation and T-cell recognition...

-> View MHC insights

Schematic diagram of an influenza A virus labeled with hemagglutinin, neuraminidase, matrix protein 1, M2, vRNP, NS1, NS2/NEP, and components nucleoprotein, lipid bilayer, and RNA polymerase

Matrix Protein 1 of Influenza A: Peptide Epitopes & Function

Matrix Protein 1 (M1) drives viral stability, uncoating, assembly, and budding. Learn about its domains, peptide epitopes, and role in the viral life cycle.

-> View M1 insights

Drawing of cancer cells and a CD8+ T cell recognizing a cancer-specific antigen

TIL Therapy in Melanoma: Peptide Tools for MAAs

An introduction to TILs in melanoma, their MAA and neoantigen targets, and strategies to enrich potent populations for therapy...

-> Explore TIL insights

Peptide Binding to MHC Class I and II Molecules

Discover how the binding grooves differ between MHC Class I and II molecules and how this affects antigen presentation and T-cell recognition...

-> View MHC insights

Matrix Protein 1 of Influenza A: Peptide Epitopes & Function

Matrix Protein 1 (M1) drives viral stability, uncoating, assembly, and budding. Learn about its domains, peptide epitopes, and role in the viral life cycle.

-> View M1 insights

TIL Therapy in Melanoma: Peptide Tools for MAAs

An introduction to TILs in melanoma, their MAA and neoantigen targets, and strategies to enrich potent populations for therapy...

-> Explore TIL insights

Enjoyed the Insights?

Connect with us on LinkedIn for a direct line to our latest updates, including:

Current trends in custom peptide synthesis & technology updates
New additions to our comprehensive Peptide Pool catalog
Scientific congresses our team is attending next
A glance behind the scenes of our laboratories in Hennigsdorf, Germany

Join our community and stay connected with our experts!

Request a Quotation

Your Contact Information

Quotation Sent!

Peptide Insights – Immunology & Virus Research with peptides&elephants

Decoding EBV: From Viral Biology to Therapeutic Target

Decoding EBV: From Viral Biology to Therapeutic Target

Cancer/Testis Antigens for Precision Immunotherapy

Cancer/Testis Antigens for Precision Immunotherapy

Peptide Binding to MHC Class I and II Molecules

Matrix Protein 1 of Influenza A: Peptide Epitopes & Function

TIL Therapy in Melanoma: Peptide Tools for MAAs

Peptide Binding to MHC Class I and II Molecules

Matrix Protein 1 of Influenza A: Peptide Epitopes & Function

TIL Therapy in Melanoma: Peptide Tools for MAAs

Enjoyed the Insights?